Wolfe Research analyst Scott Group upgrades Matson (NYSE:MATX) from Underperform to Peer Perform.
NanoVibronix Announces Agreement For Clinical Study Of UroShield At The University Of Michigan
Gathering Additional Clinical Evidence to Support Application to FDA for Permanent ClearanceNanoVibronix, Inc. (NASDAQ:NAOV), a medical device company that produces the UroShield®, PainShield® and